Chennai: Specialty chemicals company Lanxess expects that many of its customer industries will recover and therefore anticipates EBITDA pre exceptionals of between EUR 900 million and EUR 1 billion for the full year.
“We performed well in the pandemic year of 2020 and pulled off a strong finish in the fourth quarter. Our earnings margin shows that the Group’s stable position is standing the test of the crisis. I woul like to thank the entire team, who did everything possible in this difficult year to keep the business running,” said Matthias Zachert, chairman of the board of management of Lanxess AG.
“With this team and our strong position, we can tackle 2021 with optimism and focus entirely on growth”.